A new contender has entered the expanding race to translate human neural impulses into functional digital commands, seeking to bypass the operating room entirely. While Elon Musk’s Neuralink alongside peers such as Synchron, Paradromics, and Precision Neuroscience concentrate on implantable brain-computer interfaces to restore communication and mobility for paralyzed individuals, all those systems demand surgical procedures. That requirement prompted Bridge founder and CEO Will Biederman to establish an independent path, pointing out that his direction stems from a fundamental divergence in philosophy.
Biederman is not a newcomer to the sector; during his doctoral research, he created the specific silicon architecture that Neuralink licensed for its debut hardware. Yet his core objective at Bridge centers on creating an external, wearable apparatus accessible to a vastly broader public than any surgical implant could accommodate. Across the globe, barely 100 individuals have received an implanted neural interface within formal clinical evaluations, a total that includes at least 21 participants fitted with hardware from Neuralink.
The High Stakes of Invasive Brain Surgery
Undergoing a craniotomy carries inherent surgical risks, from infection to tissue scarring, which inherently restricts who can safely receive an implant. Biederman emphasizes that neurosurgical hazards cannot be brushed aside, setting an extremely high threshold for the safety profile and clinical payoff these devices must offer to justify the procedure. Plainly stated, almost nobody wants an unnecessary perforation in their skull. Consequently, invasive methods remain strictly tied to severe medical needs rather than broader assistive or general consumer adoption.
Noninvasive alternatives, however, have historically run into severe fidelity hurdles. The structural layers of human skin and cranial bone substantially attenuate electrical currents before they can ever interact with surface electrodes, degrading overall performance. This physical barrier explains why leading developers focus on tapping electrical action potentials directly at the cellular level. By placing contacts directly against brain tissue, Neuralink and similar initiatives have proven that individuals living with paralysis can direct digital interfaces, manipulate robotic limbs, and convey thoughts in real time.
Ultrasound as an Alternative to Electric Sensors
Bridge Neurotech proposes high-frequency sound waves as a practical bridge between dangerous implants and muffled surface electrical sensors. Functional ultrasound projects acoustic frequencies that reflect off moving red blood cells, charting the velocity and trajectory of hemodynamic flow. Because localized changes in blood circulation tightly mirror underlying neuronal firing patterns, tracking blood flow provides an accurate map of mental processing.
The company shares deep roots with Sam Altman-backed Merge Labs through Arbor Neuroscience, the entity formerly known as Forest Neurotech. That nonprofit was established in 2023 by Biederman alongside fellow scientists Sumner Norman and Tyson Aflalo to tackle multidisciplinary, distant-horizon projects deemed too broad for single university departments and too unproven for commercial firms. The research outfit successfully assembled an ultrasound diagnostic system that is undergoing clinical trials in the UK.
Merge Labs subsequently emerged from Forest Neurotech this past January, counting Norman and Aflalo as cofounders alongside Altman, scholar Mikhail Shapiro, and serial entrepreneurs Alex Blania and Sandro Herbig. As a result, acoustic brain-mapping has evolved into a high-profile technology sector drawing top-tier researchers and Silicon Valley venture capital.
Overcoming the Hemodynamic Delay with Predictive AI
Despite its promise, acoustic sensing presents unique physics challenges. Maryam Shanechi, a biomedical engineer at the University of Southern California, observes that since ultrasound monitors neural activity indirectly through blood movement rather than cellular electrical discharge, an unavoidable latency of several seconds occurs between actual neural firing and subsequent vascular changes. Shanechi notes that this mechanism registers a slower operational shift, which works adequately for specific use cases but poses limitations depending on the end goal.
When an application requires instantaneous responses, such as continuous mechanical limb guidance or rapid character input, a multi-second delay creates a severe operational bottleneck. Bridge intends to bridge this responsiveness gap by incorporating predictive AI models engineered to forecast intended actions and offset natural physical latency. Biederman indicated that the enterprise is exploring clinical as well as everyday consumer utilities, though he refrained from detailing precise commercial roadmaps.
Wearable Hardware and California Trials
Initial clinical testing is underway with volunteer subjects in Redwood City, California. The protocol is structured entirely as an observational trial without therapeutic or diagnostic interventions. Technicians affix a compact ultrasound sensor to the head of healthy adult participants as well as patients who previously underwent cranial surgery. Bridge’s hardware incorporates semiconductor silicon modules manufactured by portable imaging developer Butterfly Network, capturing hemodynamic signals while volunteers view imagery, listen, speak, and execute physical motions.
While Bridge has kept hardware visuals under wraps, Biederman notes that the design resembles standard audio headphones resting over the temporal window, the thinnest segment of the human cranium located slightly above the ear. Because dense bone normally scatters and absorbs acoustic waves, this thinner anatomical section offers the clearest noninvasive optical path through the skull.
Past milestones highlight the difficulty of this approach. In a 2024 trial conducted by investigators at Caltech and the University of Southern California, researchers proved that acoustic interfaces could successfully reconstruct complex neural intent, but the procedure required excising a bone fragment and inserting an acoustic window. Completely eliminating the requirement for that synthetic opening represents Bridge’s core scientific hurdle. Biederman remains firm that the greatest societal promise lies in noninvasive devices, betting that external wearables will ultimately bring neural computing to the masses.
